Schedule 13G filing

GordonMD Global Investments LP disclosed a 16.4% stake in Pyxis Oncology, Inc. (PYXS)

Schedule 13G · Filed Oct 9, 2026

GordonMD Global Investments LP reported owning 16.4% of Pyxis Oncology, Inc. (PYXS) (20,441,948 shares) in a Schedule 13G filed Oct 9, 2026.

A 13G is a passive stake: the holder does not plan to push for changes.

Stake

Pyxis Oncology, Inc.

Stake

16.4% stake

More PYXS insider and Congress trades

Share this trade

From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.